Laurus Labs Limited (NSE:LAURUSLABS)
India · Delayed Price · Currency is INR 1,166.40
+65.45 (5.94%)
May 4, 2026, 3:29 PM IST
Laurus Labs Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 8,888 | 3,583 | 1,606 | 7,901 | 8,275 |
Depreciation & Amortization | 4,801 | 4,242 | 3,797 | 3,190 | 2,472 |
Other Amortization | - | 58.5 | 49.1 | 51.3 | 43.3 |
Loss (Gain) From Sale of Assets | 74.8 | -570.5 | 19.3 | 2.1 | 12.1 |
Stock-Based Compensation | 109.4 | 102.3 | 109.2 | 74.8 | 66.4 |
Other Operating Activities | 2,112 | 2,347 | 1,367 | 1,873 | 1,659 |
Change in Accounts Receivable | -1,810 | -4,050 | -851 | -2,279 | -515.8 |
Change in Inventory | -4,056 | -828.6 | -1,513 | 818.3 | -1,743 |
Change in Accounts Payable | 2,743 | -979.9 | 3,344 | -1,689 | -3,012 |
Change in Other Net Operating Assets | 3,374 | 2,112 | -1,270 | -3.6 | 1,855 |
Operating Cash Flow | 16,235 | 6,017 | 6,657 | 9,939 | 9,111 |
Operating Cash Flow Growth | 169.84% | -9.62% | -33.02% | 9.09% | 24.30% |
Capital Expenditures | -10,700 | -6,410 | -6,783 | -9,902 | -8,768 |
Sale of Property, Plant & Equipment | 68.1 | 998.7 | 23 | 26.7 | 1.2 |
Cash Acquisitions | - | - | -716 | - | - |
Investment in Securities | -757.2 | -1,054 | -800.2 | -223 | -276 |
Other Investing Activities | 502 | -352.4 | 52.1 | 137.3 | -100.2 |
Investing Cash Flow | -10,887 | -6,817 | -8,224 | -9,961 | -9,143 |
Short-Term Debt Issued | - | 3,239 | 3,939 | 849.5 | 239.7 |
Long-Term Debt Issued | 2,726 | 1,789 | 3,639 | 3,835 | 4,140 |
Total Debt Issued | 2,726 | 5,028 | 7,577 | 4,685 | 4,380 |
Short-Term Debt Repaid | -2,450 | - | - | - | - |
Long-Term Debt Repaid | -3,404 | -3,466 | -2,500 | -2,547 | -2,412 |
Total Debt Repaid | -5,853 | -3,466 | -2,500 | -2,547 | -2,412 |
Net Debt Issued (Repaid) | -3,127 | 1,561 | 5,078 | 2,138 | 1,968 |
Issuance of Common Stock | 200 | 101.7 | 25.6 | 74.4 | 43.1 |
Common Dividends Paid | -863.3 | -431.3 | -861.8 | -1,075 | -858.6 |
Dividends Paid | -863.3 | -431.3 | -861.8 | -1,075 | -858.6 |
Other Financing Activities | -1,457 | -839 | -1,743 | -1,404 | -850 |
Financing Cash Flow | -5,247 | 392.8 | 2,498 | -266.4 | 302.6 |
Foreign Exchange Rate Adjustments | 30 | 13.9 | 1.7 | -8.8 | -1.3 |
Net Cash Flow | 131.2 | -394 | 932.7 | -296.8 | 268.9 |
Free Cash Flow | 5,536 | -393.5 | -126.2 | 37.4 | 342.6 |
Free Cash Flow Growth | - | - | - | -89.08% | -22.54% |
Free Cash Flow Margin | 8.06% | -0.71% | -0.25% | 0.06% | 0.69% |
Free Cash Flow Per Share | 10.24 | -0.73 | -0.23 | 0.07 | 0.64 |
Cash Interest Paid | - | 2,092 | 1,743 | 1,404 | 850 |
Cash Income Tax Paid | 2,939 | 1,375 | 1,046 | 2,855 | 1,823 |
Levered Free Cash Flow | -226.05 | -3,454 | -2,442 | -3,951 | -644.88 |
Unlevered Free Cash Flow | 841.01 | -2,162 | -1,369 | -3,183 | -171.38 |
Change in Working Capital | 250.8 | -3,746 | -290.2 | -3,153 | -3,416 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.